StockNews.com Initiates Coverage on Retractable Technologies (NYSE:RVP)

Equities research analysts at StockNews.com assumed coverage on shares of Retractable Technologies (NYSE:RVPGet Free Report) in a research report issued on Monday. The firm set a “hold” rating on the stock.

Retractable Technologies Stock Up 1.2 %

Shares of Retractable Technologies stock opened at $0.72 on Monday. The company has a current ratio of 9.51, a quick ratio of 6.54 and a debt-to-equity ratio of 0.01. Retractable Technologies has a 12-month low of $0.70 and a 12-month high of $1.34. The company has a market cap of $21.55 million, a P/E ratio of -1.17 and a beta of 2.06. The company’s fifty day simple moving average is $0.79 and its two-hundred day simple moving average is $0.97.

Retractable Technologies (NYSE:RVPGet Free Report) last announced its quarterly earnings results on Wednesday, August 14th. The company reported ($0.48) earnings per share (EPS) for the quarter. Retractable Technologies had a negative net margin of 46.72% and a negative return on equity of 18.67%. The company had revenue of $6.03 million for the quarter.

Insider Transactions at Retractable Technologies

In other news, CEO Thomas J. Shaw purchased 71,422 shares of the company’s stock in a transaction that occurred on Friday, September 20th. The shares were bought at an average cost of $0.82 per share, for a total transaction of $58,566.04. Following the completion of the transaction, the chief executive officer now directly owns 14,743,907 shares of the company’s stock, valued at $12,090,003.74. This trade represents a 0.00 % increase in their position. The acquisition was disclosed in a document filed with the SEC, which can be accessed through the SEC website. In the last quarter, insiders bought 171,913 shares of company stock valued at $137,748. Corporate insiders own 55.00% of the company’s stock.

Institutional Investors Weigh In On Retractable Technologies

A hedge fund recently bought a new stake in Retractable Technologies stock. PFG Investments LLC purchased a new position in Retractable Technologies, Inc. (NYSE:RVPFree Report) during the third quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 34,600 shares of the company’s stock, valued at approximately $27,000. PFG Investments LLC owned approximately 0.12% of Retractable Technologies as of its most recent SEC filing. Institutional investors own 7.58% of the company’s stock.

Retractable Technologies Company Profile

(Get Free Report)

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.

Featured Stories

Receive News & Ratings for Retractable Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Retractable Technologies and related companies with MarketBeat.com's FREE daily email newsletter.